Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | Suite 550 - 375 Water Street VANCOUVER BC V6B 5C6 |
Tel: | 1-604-6287266 |
Website: | https://www.well.company |
IR: | See website |
Key People | ||
Hamed Shahbazi Executive Chairman of the Board, Chief Executive Officer | Eva Fong Chief Financial Officer | Jay Kreger Chief Executive Officer of CRH Medical Corporation |
Amir Javidan Chief Operating Officer | Beemal Shahl Chief Operating Officer of CRH Medical Corporation |
Business Overview |
WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare's in Canada with 165 clinics supporting primary care, specialized care and diagnostic services. |
Financial Overview |
For the three months ended 31 March 2024, WELL Health Technologies Corp revenues increased 37% to C$231.6M. Net income totaled C$15.1M vs. loss of C$14.4M. Revenues reflect United States (Country) segment increase of 42% to C$140.4M, Canada (Country) segment increase of 30% to C$91.1M. Net Income reflects Change in fair value of investments increase from C$0K to C$14M (income). |
Employees: | 2,200 as of Dec 31, 2023 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $1,307M as of Mar 31, 2024 |
Annual revenue (TTM): | $838.19M as of Mar 31, 2024 |
EBITDA (TTM): | $106.79M as of Mar 31, 2024 |
Net annual income (TTM): | $29.53M as of Mar 31, 2024 |
Free cash flow (TTM): | $59.46M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $383.89M as of Mar 31, 2024 |
Shares outstanding: | 243,232,535 as of May 14, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |